Publication | Open Access
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
15
Citations
31
References
2020
Year
Psychiatric EvaluationPsychiatric DisordersPsychotropic MedicationPharmacotherapyMental HealthPsychologySocial SciencesCovid-19Clinical PsychologyDecember 2020SecMental Health ServicesPotential Antipsychotic ChoicePsychiatric DiseasePsychiatryOpinion Article FrontCovid-19 PandemicClinical PsychiatryPsychiatric DisorderPsychopharmacology Volume 11Psychotic DisorderSchizophreniaMood DisordersBiological PsychiatryMedicinePsychopathology
OPINION article Front. Psychiatry, 23 December 2020Sec. Psychopharmacology Volume 11 - 2020 | https://doi.org/10.3389/fpsyt.2020.612347
| Year | Citations | |
|---|---|---|
Page 1
Page 1